Indian Pharmaceutical Alliance appoints Zydus Lifesciences MD Sharvil Patel as new president

Indian Pharmaceutical Alliance appoints Zydus Lifesciences MD Sharvil Patel as new president


The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel, Managing Director of Zydus Lifesciences as its new President.

Patel succeeds Samir Mehta, Chairman, Torrent Group, the industry body said in an announcement on Friday.

The IPA leadership team also includes Glenn Saldanha, Chairman and Managing Director, Glenmark, who has been appointed as Vice President.

The leadership transition comes at a pivotal moment for the Indian pharmaceutical industry with recent GST reforms setting the stage for a more affordable healthcare ecosystem while at the same time India continues to strengthen its position as a hub for specialty medicines, biosimilars, and cutting-edge therapies.

Patel of Zydus Lifesciences said: “Building on this foundation, breakthroughs at Zydus, such as India’s first NCE, our foray into MedTech and the global CDMO business, and our advances in vaccines and biologics, inspire my vision to build a strong, self-reliant India.”


Saldanha added: “Our recent global partnership with AbbVie is a strong example of how Indian pharma is moving up the innovation curve, and together we will strengthen India’s leadership in delivering high-quality, affordable, and future-ready healthcare solutions.”Sudarshan Jain, Secretary General, IPA, said: “The Indian Pharmaceutical Industry has been playing a vital role in advancing the industry’s vision for patient care and access. With the new leadership team, we will continue to build on recent reforms and breakthroughs with a focus on innovation, patient access, and the highest standards of quality in healthcare.”

Add ET Logo as a Reliable and Trusted News Source



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *